Paid and presented by Pfizer. For people undergoing treatment for cancer, who are at greater risk of infection, antimicrobial ...

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

For the past three years, biotechs and pharmas have renamed, rebranded and more in a bid to refresh their corporate appeal. ...

Home buyers scooped up everything from a rustic respite in Clinton with its own pond and gardens to a cutting-edge new build ...

A 'game-changer' anti-smoking pill set to be rolled out on the NHS has been linked to more than 25,000 reports of side ...

Top 15. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other dividend contenders. Dividend stocks have long been favored by investors for the income ...

With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in ...

Naomi’s most recent, and perhaps most important, contribution to the public debate has been editing the now released ...

The business contact information for 122 million people circulating since February 2024 is now confirmed to have been stolen ...

Sanofi gets rated buy today, agreeing with bullish ratings from the Wall Street and SA analysts' consensus. With a diverse ...

The new partnership builds on earlier collaborations like the Spokes Project that saw SSPC and NIBRT work with Allergan, ...

Sandoz Inc.’s proposed generic version of Inlyta infringes a patent for the kidney-cancer chemotherapy treatment, Pfizer Inc.